Christie Group PLC
04 August 2026
4 August 2026
Christie Group plc
("Christie Group" or the "Company")
Christie & Co launches dedicated dental brokerage service in the Republic of Ireland
Christie Group plc (CTG.L), is pleased to report that its agency and advisory business, Christie & Co, has expanded into the Republic of Ireland dental market. This brings the UK's largest dedicated dental brokerage and advisory team to a new market, to support a sector experiencing growing investor and operator interest.
With more than 90 years of experience in the business property sector, Christie & Co operates across the UK and Europe, providing brokerage, valuation, consultancy, and advisory services to clients across a range of specialist sectors.
The firm's award-winning dental team comprises 35 specialists and is the largest dedicated dental brokerage and advisory team in the UK. In 2025 alone, Christie & Co advised on, agreed, or completed the sale of 1,241 dental practices with a combined value exceeding £1.7 billion through its agency, advisory, and professional services teams.
The move into the Republic of Ireland marks a significant milestone in Christie & Co's growth strategy and further strengthens its position as the leading adviser to the dental sector. The broker has just been engaged on a sell-side mandate for the divestment of 20 dental practices across the country, underlining both the appetite from practice owners exploring strategic options and the strength of buyer demand.
Leading the expansion will be Paul Graham (Managing Director - Medical, Christie & Co), who comments: "Following the success of our dental brokerage business in the UK, expanding into the Republic of Ireland is a natural next step for us. We identified a clear opportunity and demand to bring our specialist expertise to a market with a dynamic and evolving dental sector, and we are already seeing strong interest from both buyers and sellers."
Dan Prickett, Chief Executive of Christie Group plc, comments: "We are delighted to expand our market-leading dental sector presence beyond the UK as we continue to progress our strategic plan to develop a multi-sector offering in Europe."
Enquiries:
Christie Group plc
Dan Prickett 07885 813101
Chief Executive
Simon Hawkins 07767 354366
Chief Financial Officer
Shore Capital
Patrick Castle 020 7408 4090
Nominated Advisor and Broker
Hudson Sandler
Alex Brennan / Lottie Lambert/ Emily Brooker 020 7796 4133 / christiegroup@hudsonsandler.com
Financial PR
Notes to Editors:
Christie Group plc, quoted on AIM, is a leading professional business services group with 32 offices across the UK and Europe, catering to its specialist markets in the healthcare, hospitality, leisure, medical, childcare & education and retail sectors.
Christie Group operates in two complementary business divisions: Professional & Financial Services (PFS) and Stock & Inventory Systems & Services (SISS). These divisions trade under the brand names: PFS - Christie & Co, Pinders, Christie Finance and Christie Insurance: SISS - Venners.
Tracing its origins back to 1896, the Group has a long-established reputation for offering valued services to client companies in agency, valuation services, investment, consultancy, project management, stock audit and inventory management. The diversity of these services provides a natural balance to the Group's core agency business.
For more information, please go to https://www.christiegroup.com/
More about our services:
https://www.christie.com/ https://www.christieinsurance.com/ https://www.christiefinance.com https://www.pinders.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.